Stock Incentive Plans (Tables)

6 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

The following table summarizes stock option activity during the six months ended June 30, 2026:


	Number of Shares	Weighted- Average Exercise Price
Stock options outstanding at December 31, 2025	2,478,871	$	20.47

Exercised	(137,204)	9.87
Forfeited	(16,591)	17.49
Expired	(27,326)	26.69
Stock options outstanding at June 30, 2026	2,297,750	21.05
Stock options exercisable at June 30, 2026	1,846,811	$	22.81

Summary of RSUs Activity

The following table summarizes restricted stock units, or RSUs, and performance restricted stock units, or PSUs, activity during the six months ended June 30, 2026:


	Number of Shares	Weighted- Average Grant Date Fair Value
RSUs and PSUs outstanding at December 31, 2025	3,930,939	$	15.54
RSUs granted	1,110,847	20.16
RSUs vested	(1,165,785)	15.01
RSUs forfeited	(506,505)	15.21
PSUs granted	570,634	20.46
PSUs vested	(118,304)	18.99
PSUs forfeited	(70,806)	18.88
RSUs and PSUs outstanding at June 30, 2026	3,751,020	$	17.67

Summary of PSUs Activity

The following table summarizes restricted stock units, or RSUs, and performance restricted stock units, or PSUs, activity during the six months ended June 30, 2026:


	Number of Shares	Weighted- Average Grant Date Fair Value
RSUs and PSUs outstanding at December 31, 2025	3,930,939	$	15.54
RSUs granted	1,110,847	20.16
RSUs vested	(1,165,785)	15.01
RSUs forfeited	(506,505)	15.21
PSUs granted	570,634	20.46
PSUs vested	(118,304)	18.99
PSUs forfeited	(70,806)	18.88
RSUs and PSUs outstanding at June 30, 2026	3,751,020	$	17.67

Summary of Expense Relating to Employee and Nonemployee Stock-Based Payment Awards from Stock Options and RSUs

The following table summarizes stock-based compensation expense relating to employee and non-employee stock-based awards for the three and six months ended June 30, 2026 and 2025, included in the condensed consolidated statements of operations as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Cost of testing services	$	200	$	329	$	465	$	692
Cost of product	15		108		104		339
Cost of patient and digital solutions	106		189		240		409
Research and development	1,121		1,407		2,444		2,766
Sales and marketing	1,566		2,146		3,401		4,730
General and administrative	7,646		5,245		13,803		9,419
Total	$	10,654	$	9,424	$	20,457	$	18,355